Page last updated: 2024-08-23

escitalopram and Anxiety Neuroses

escitalopram has been researched along with Anxiety Neuroses in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's10 (100.00)2.80

Authors

AuthorsStudies
Baumel, WT; Cecil, KM; Gong, Q; Huang, X; Li, H; Lu, L; Mills, JA; Mossman, SA; Schroeder, HK; Strawn, JR; Sweeney, JA1
Belz, M; Degner, D; Greil, W; Grohmann, R; Köberle, U1
Baker, AW; Bui, E; Dutton, MA; Hoge, EA; Mete, M; Simon, NM1
Chu, L; Li, D; Li, J; Li, R; Liu, Y; Luo, X; Zhang, J; Zhang, Y1
Bertzos, K; Eisenberg, B; Gopalkrishnan, M; Greenberg, E; Hahn, RD; Knutson, JA; Liu, C; McVoy, M; Moldauer, L; Strawn, JR; Wise, A1
Slawson, DC1
Armstrong, CH; Grillon, C; Hoge, EA; Lago, TR; Lazar, SW; Mete, M; Oliva, I1
Ji, X; Liu, M; Wang, Y; Yang, X; Zhou, C1
Hengartner, MP; Horowitz, MA; Plöderl, M1
Blumenthal, JA; Davidson, J; Hinderliter, A; Hoffman, BM; Jiang, W; Kraus, WE; Liao, L; Sherwood, A; Smith, PJ; Watkins, LL1

Trials

6 trial(s) available for escitalopram and Anxiety Neuroses

ArticleYear
Acute neurofunctional effects of escitalopram during emotional processing in pediatric anxiety: a double-blind, placebo-controlled trial.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2022, Volume: 47, Issue:5

    Topics: Adolescent; Anxiety; Anxiety Disorders; Child; Double-Blind Method; Emotions; Escitalopram; Humans; Magnetic Resonance Imaging; Selective Serotonin Reuptake Inhibitors

2022
Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial.
    JAMA psychiatry, 2023, 01-01, Volume: 80, Issue:1

    Topics: Adult; Anxiety; Anxiety Disorders; Escitalopram; Female; Humans; Male; Mindfulness; Stress, Psychological; Treatment Outcome

2023
A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder.
    Journal of child and adolescent psychopharmacology, 2023, Volume: 33, Issue:3

    Topics: Adolescent; Anxiety Disorders; Child; Citalopram; Double-Blind Method; Escitalopram; Humans; Nucleotidyltransferases; Treatment Outcome

2023
Clinical efficacy of escitalopram combined with botulinum toxin A in patients with generalized anxiety disorder and comorbid headache.
    Psychopharmacology, 2023, Volume: 240, Issue:10

    Topics: Anxiety Disorders; Botulinum Toxins, Type A; Comorbidity; Escitalopram; Female; Headache; Humans; Male; Prospective Studies; Treatment Outcome

2023
Re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder" by Strawn et al.-Concerning Harm-Benefit Ratio in a Recent Trial About Escitalopram for Generalized Anxiety Disorder.
    Journal of child and adolescent psychopharmacology, 2023, Volume: 33, Issue:7

    Topics: Adolescent; Anxiety Disorders; Child; Escitalopram; Humans

2023
Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease: The Understanding the Benefits of Exercise and Escitalopram in Anxious Patients With Coronary Heart Disease (UNWIND) Randomized Clinical Trial.
    JAMA psychiatry, 2021, 11-01, Volume: 78, Issue:11

    Topics: Aged; Anxiety Disorders; Comorbidity; Coronary Disease; Depression; Escitalopram; Exercise Therapy; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Selective Serotonin Reuptake Inhibitors

2021

Other Studies

4 other study(ies) available for escitalopram and Anxiety Neuroses

ArticleYear
[Effect of the direct healthcare professional communication on citalopram and escitalopram drug utilization for inpatient treatment of anxiety disorders].
    Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2022, Volume: 65, Issue:11

    Topics: Anxiety Disorders; Citalopram; Communication; Delivery of Health Care; Drug Utilization; Escitalopram; Germany; Humans; Inpatients

2022
Serum BDNF levels are involved in the diagnosis and treatment response in patients with PD.
    Journal of affective disorders, 2023, 04-14, Volume: 327

    Topics: Anxiety; Anxiety Disorders; Brain-Derived Neurotrophic Factor; Escitalopram; Humans; Panic Disorder

2023
Mindfulness-Based Stress Reduction Is Noninferior to Escitalopram for Adults With Anxiety Disorder.
    American family physician, 2023, Volume: 107, Issue:6

    Topics: Adult; Anxiety; Anxiety Disorders; Escitalopram; Humans; Mindfulness; Stress, Psychological

2023
Attenuation of Anxiety-Potentiated Startle After Treatment With Escitalopram or Mindfulness Meditation in Anxiety Disorders.
    Biological psychiatry, 2024, Jan-01, Volume: 95, Issue:1

    Topics: Adult; Anxiety; Anxiety Disorders; Escitalopram; Humans; Meditation; Mindfulness; Reflex, Startle

2024